Aspect Analytics develops enterprise software to analyze imaging mass spectrometry (IMS) data. IMS technology is gaining significant traction in life science R&D and is steadily maturing into a key enabler in drug development, biomarker discovery, and clinical tissue pathology. With IMS commonly generating tens to hundreds of gigabytes of complex data in a single experiment, data analysis is becoming a critical bottleneck in the adoption of this emerging technology.
Aspect Analytics unleashes the full potential of IMS by bridging the gap between algorithmic development in bioinformatics research and enterprise-grade software platforms to support key IMS-based applications. Our software can (i) extract maximal knowledge from IMS data, (ii) scale up for high-throughput applications and (iii) provide integrated data management, traceability and more.